Drug research

ARD-101

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
ARD-101 for Treatment of PWS: The Hunger Elimination or Reduction Objective TrialNCT06828861	AARD	Phase 3	Terminated	2026-05-07Actual
The Hunger Elimination or Reduction Objective (HERO ) Open -Label Extension (OLE) TrialNCT07197034	AARD	Phase 3	Terminated	2026-04-15Actual
Study to Evaluate ARD-101 in Adults Receiving Bariatric SurgeryNCT05215847	AARD	Phase 2	Completed	2023-02-03Actual
Study to Evaluate ARD-101 in Adults With ObesityNCT05121441	AARD	Phase 2	Completed	2022-11-09Actual
A Study of Oral ARD-101 in Patients With Prader-Willi SyndromeNCT05153434	AARD	Phase 2	Completed	2024-09-24Actual

AARDTerminatedPrimary completion: 2026-05-07 · Actual

Trial details

AARDTerminatedPrimary completion: 2026-04-15 · Actual

Trial details

AARDCompletedPrimary completion: 2023-02-03 · Actual

Trial details

AARDCompletedPrimary completion: 2022-11-09 · Actual

Trial details

AARDCompletedPrimary completion: 2024-09-24 · Actual

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.